We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+4.94%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$1.35B
AUM Growth
+$25.5M
Cap. Flow
+$32.7M
Cap. Flow %
2.42%
Top 10 Hldgs %
12.05%
Holding
2,121
New
584
Increased
441
Reduced
528
Closed
563

Top Sells

Rank Stock Value
1
LMND icon
Lemonade
LMND
+$4.64M
2
MGNI icon
Magnite
MGNI
+$3.66M
3
RELY icon
Remitly
RELY
+$3.66M
4
MNRO icon
Monro
MNRO
+$3.65M
5
VGR
Vector Group Ltd.
VGR
+$3.32M

Sector Composition

Rank Sector Weight
1 Technology 16.19%
2 Healthcare 13.13%
3 Financials 12.64%
4 Consumer Discretionary 12.16%
5 Industrials 9.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMUX icon
1501
Immunic
IMUX
$195M
$116K 0.01%
11,594
+8,317
+254% +$105K
OVID icon
1502
Ovid Therapeutics
OVID
$491M
$115K 0.01%
123,583
-136,926
-53% -$153K
DHC
1503
Diversified Healthcare Trust
DHC
$2.14B
$111K 0.01%
48,154
-106,456
-69% -$313K
ONTF
1504
DELISTED
ON24
ONTF
$111K 0.01%
17,214
-55,605
-76% -$357K
ARDX icon
1505
Ardelyx
ARDX
$997M
$109K 0.01%
+21,475
New +$119K
FTCI icon
1506
FTC Solar
FTCI
$44.9M
$107K 0.01%
19,492
-74,494
-79% -$340K
AUPH icon
1507
Aurinia Pharmaceuticals
AUPH
$2.11B
$106K 0.01%
11,758
-113,887
-91% -$929K
IHRT icon
1508
iHeartMedia
IHRT
$583M
$106K 0.01%
53,662
-431,434
-89% -$913K
IBRX icon
1509
ImmunityBio
IBRX
$8.1B
$105K 0.01%
41,031
-66,954
-62% -$279K
VTEX icon
1510
VTEX
VTEX
$713M
$105K 0.01%
17,821
-70,146
-80% -$460K
DM
1511
DELISTED
Desktop Metal, Inc.
DM
$101K 0.01%
+42,957
New +$182K
OPRX icon
1512
OptimizeRx
OPRX
$133M
$100K 0.01%
+20,661
New +$115K
SAGE
1513
DELISTED
Sage Therapeutics
SAGE
$96K 0.01%
+17,674
New +$108K
AMPX icon
1514
Amprius Technologies
AMPX
$1.73B
$94K 0.01%
+33,542
New +$58.6K
FDMT icon
1515
4D Molecular Therapeutics
FDMT
$562M
$93K 0.01%
16,743
-20,919
-56% -$164K
UA icon
1516
Under Armour Class C
UA
$2.53B
$92K 0.01%
+12,397
New +$103K
DLTH icon
1517
Duluth Holdings
DLTH
$159M
$90K 0.01%
29,184
-75,579
-72% -$275K
SPCE icon
1518
Virgin Galactic
SPCE
$398M
$90K 0.01%
+15,263
New +$102K
UAA icon
1519
Under Armour
UAA
$2.6B
$86K 0.01%
+10,423
New +$95.3K
AMPS
1520
DELISTED
Altus Power
AMPS
$86K 0.01%
21,158
-68,738
-76% -$252K
NNOX icon
1521
Nano X Imaging
NNOX
$73.8M
$76K 0.01%
+10,512
New +$67.3K
BIOA
1522
BioAge Labs
BIOA
$538M
$70K 0.01%
+12,146
New +$209K
PL icon
1523
Planet Labs
PL
$8.53B
$66K ﹤0.01%
16,435
+5,472
+50% +$17K
RLMD icon
1524
Relmada Therapeutics
RLMD
$527M
$65K ﹤0.01%
124,773
+16,361
+15% +$39.9K
SIGA icon
1525
SIGA Technologies
SIGA
$219M
$63K ﹤0.01%
+10,491
New +$70.1K

Similar funds

GSA Capital Partners's Q4 2024 Portfolio in Review

As of Q4 2024, GSA Capital Partners held 2,121 positions worth $1.35B, up 1.9% from $1.32B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

GSA Capital Partners's Q4 2024 filing shows 584 new, 441 increased, 528 reduced and 563 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 165,180 shares worth $97.2M. The largest sale was Lemonade, an estimated $4.64M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.

  • GSA Capital Partners's largest Q4 2024 buy was iShares Core S&P 500 ETF: 165,180 shares worth $97.2M.
  • GSA Capital Partners added most to Frontline in Q4 2024, an estimated $5.7M increase.
  • GSA Capital Partners's biggest Q4 2024 reduction was Lemonade, cutting an estimated $4.64M.
  • GSA Capital Partners fully exited Monro in Q4 2024, selling an estimated $3.65M.
  • GSA Capital Partners's ten largest holdings make up 12% of its $1.35B portfolio in Q4 2024.
  • GSA Capital Partners opened 584 new positions and closed 563 in Q4 2024.
  • GSA Capital Partners's portfolio value rose 1.9% quarter-over-quarter to $1.35B.

Based on GSA Capital Partners's 13F filing for Q4 2024, filed 7 Feb 2025.